The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
Also known as: Iron and TIBC, Iron and Total Iron Binding Capacity TIBC, TIBC
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
Also known as: Reverse T3, Reverse Triiodothyronine, RT3, T3 Reverse RT3 LCMSMS, Triiodothyronine Reverse
Also known as: Triiodothyronine
Also known as: Free T3, FT3, T3 Free
Also known as: T4 Thyroxine Total
Also known as: Free T4, FT4, T4 Free
Also known as: Thyroid Stimulating Hormone, Thyroid Stimulating Hormone (TSH), Thyrotropin
Also known as: B12, B12 Vitamin, Cobalamin, Cyanocobalamin, Vitamin B12 Cobalamin
Also known as: B6, B6 Vitamin, Pyridoxal, Pyridoxal Phosphate, Pyridoxal Phosphate (PLP), Vitamin B6 Pyridoxal Phosphate
The TH-3. Hyperthyroidism panel contains 15 tests with 82 biomarkers.
Brief Description: The TH-3 Hyperthyroidism panel is a detailed diagnostic tool designed to assess the function of the thyroid gland in the context of hyperthyroidism. It includes a broad spectrum of tests that evaluate not only thyroid hormones and antibodies but also the impact of hyperthyroidism on various bodily functions, including metabolism, blood health, and nutritional status.
Collection Method: Blood Draw
Specimen Type: Whole Blood, Serum, and Plasma
Test Preparation: Patient should be fasting 9-12 hours prior to collection.
Patient must be restricted from alcohol and vitamins for at least 24 hours before a sample collection.
Collection should be done in the morning.
Specifc to TSH: Specimen collection after fluorescein dye angiography should be delayed for at least 3 days. For patients on hemodialysis, specimen collection should be delayed for 2 weeks.
According to the assay manufacturer Siemens: "Samples containing fluorescein can produce falsely depressed values when tested with the Advia Centaur TSH3 Ultra assay."
Healthcare providers typically order the TH-3 Hyperthyroidism panel for individuals exhibiting signs and symptoms of hyperthyroidism, such as unintentional weight loss, palpitations, increased sweating, anxiety, and heat intolerance. This panel is particularly useful in identifying the underlying cause of hyperthyroidism, including autoimmune thyroid diseases like Graves' disease, and in monitoring the effectiveness of treatment. It is also valuable for assessing the systemic effects of hyperthyroidism and managing associated complications.
While the TH-3 Hyperthyroidism panel offers a comprehensive evaluation of hyperthyroidism and its effects, the TH-4 Hyperthyroidism panel expands on this by including tests for TSH Receptor Binding Antibody and Thyroid Stimulating Immunoglobulin. These additional tests are particularly valuable in diagnosing and managing Graves' disease, providing a more detailed understanding of the autoimmune aspects of hyperthyroidism. The TH-4 panel is therefore ideal for complex cases where a more nuanced understanding of the disease is necessary for effective treatment.
The TH-3 Hyperthyroidism panel is designed to diagnose and manage hyperthyroidism, including its most common cause, Graves' disease. It also helps in identifying autoimmune thyroiditis and assessing the risk of complications such as osteoporosis, cardiovascular disease, and diabetes, which can be associated with or exacerbated by hyperthyroidism.
Healthcare professionals use the results of the TH-3 Hyperthyroidism panel to diagnose hyperthyroidism, determine its underlying cause, and assess the effectiveness of treatment. The comprehensive metabolic and nutritional assessments allow for the management of related conditions, ensuring a holistic approach to patient care.
The TH-3 Hyperthyroidism panel provides an in-depth evaluation of hyperthyroidism, offering valuable insights into thyroid function, autoimmune status, and the broader health impacts of thyroid dysfunction. By combining thyroid function tests with assessments for autoimmune markers, metabolic health, and nutritional status, this panel enables healthcare providers to develop targeted treatment strategies, addressing the complexities of hyperthyroidism and enhancing patient care.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.